18
Participants
Start Date
February 28, 2010
Primary Completion Date
March 31, 2016
Study Completion Date
June 24, 2016
Bevacizumab
15 mg/kg, IV every 21 days x 6 cycles.
Paclitaxel
"Regimen A / Treatment 1: 200 mg/m² IV over 3 hours every 21 days.~Regimen B / Treatment 2: 90 mg/m² weekly x 3 of a 28-day cycle"
MD Anderson Sarcoma Center, Houston
Santa Monica Sarcoma Center, Santa Monica
Stanford University Medical Center, Stanford
Collaborators (1)
Genentech, Inc.
INDUSTRY
Stanford University
OTHER